Investigation an Antifungal Activity of Diclofenac Sodium against Hyphae Formation in Aspergillus Fumigatus with Attention to the Expression of Ef-1 Gene
Abstract
No Abstract####
Ben‐Ami R, Lewis RE, Kontoyiannis DP (2010). Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. Br J Haematol, 150(4):406-17.
Dagenais TR, Keller NP (2009). Pathogenesis of Aspergillus fumigatus in invasive aspergillosis. Clin Microbiol Rev, 22(3):447-65.
Lin S-J, Schranz J, Teutsch SM (2001). Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis, 32(3):358-66.
Johnson A, Lewis J (2002). Molecular biology of the cell 4th ed. New York: Garland Science.
Sallmann AR (1986). The history of diclofenac. Am J Med, 80(4):29-33.
Dutta NK, Mazumdar K, Dastidar SG, Park J-H (2007). Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice. Int J Antimicrob Agents, 30(4):336-40.
Umaru T, Nwamba CO, Kolo I, Nwodo UU (2009). Antimicrobial activity of non-steroidal anti-inflammatory drugs with respect to immunological response: Diclofenac sodium as a case study. Afr J Biotechnol, 8(25):7332-39.
Allen K, Arca M, Bakovic M et al (2012). Prostaglandins, Leukotrienes and Essential Fatty Acids. Prostaglandins Leukot Essent Fatty Acids, 87:209.
Wayne P (2008). Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-; CLSI document M38-A2. CLSI 2008a 28:6-12.
McGookin R (1984). RNA extraction by the guanidine thiocyanate procedure. Nucleic Acids: Springer;. p. 113-6.
| Files | ||
| Issue | Vol 47 No 5 (2018) | |
| Section | Letter to the Editor | |
| Keywords | ||
| No keywords## | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
